MOONZIN, created in 2003 (Netherlands), from
402 sister brands
and 17478 competing brands.
MOONZIN is owned by Merck & Co, listed on the stock exchange of New York
The sector of MOONZIN is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.